287 filings
Page 14 of 15
6-K
gtmof c79zzvgdv9
10 Aug 05
Current report (foreign)
12:00am
6-K
vogt878f13p01qmw
5 Jul 05
Current report (foreign)
12:00am
6-K
8w9z pqwlbyxk
16 Jun 05
Ym Biosciences Expands Development Program for Egfr Inhibitor Nimotuzumab
12:00am
6-K
2196cidy1e1t8m
25 May 05
Ym Biosciences Achieves Primary Objective with Norelin™ Study
12:00am
6-K
sipmpy43u8jmc3
20 May 05
Ym Biosciences and Cimab Achieve Clinical Milestone
12:00am
6-K
rywfe4uh2f66p0x
19 May 05
Current report (foreign)
12:00am
6-K
rt2jey
13 May 05
Ym Biosciences Reports Third Quarter 2005 Operational and Financial Results
12:00am
6-K
tiq 1cey0dfa8ae
13 May 05
Current report (foreign)
12:00am
6-K
ncr1v04ot 9d7kl
3 May 05
Current report (foreign)
12:00am
6-K
r6gv6wr
14 Apr 05
Ym Biosciences to Acquire Delex Therapeutics
12:00am
6-K
spgd0393g 7ngkua
16 Mar 05
Ym Biosciences’ Theracim Receives Investigator Sponsored Ind from Fda
12:00am
6-K
xlvj0cn0h8d1z
28 Feb 05
Ym Biosciences and Oncoscience Report Response Rate of 35.3% In Pediatric Glioma
12:00am
6-K
jj6g0kkn
11 Feb 05
Ym Biosciences Reports Second Quarter 2005
12:00am
6-K
iplmi
11 Feb 05
Current report (foreign)
12:00am
6-K
fbfcv5sp
31 Jan 05
Ym Biosciences Expands Development Program for Lead Cancer Drug
12:00am
6-K
k46y torqwk5o7wt
25 Jan 05
Ym Biosciences and Oncoscience Achieve Clinical Milestone
12:00am
6-K
jh798bm5
21 Dec 04
Ym Biosciences Reports Positive Egf-r Antibody Pivotal Phase Ii Results
12:00am
6-K
v1pxkkezyuyjqsujlsg
15 Dec 04
YM BioSciences Annual and Special Meeting Update
12:00am
6-K
shwlfebfsfj2
3 Dec 04
Ym Biosciences Inc.
12:00am
6-K
l0ehskb0izioqynlnbs
2 Dec 04
Current report (foreign)
12:00am